ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,660.00
0.33%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36885
0.08%
Bitcoin
62,903.20
-0.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PAVmed Inc (PAVMZ)

  7. PAVmed Inc (PAVMZ) News

PAVMZ

PAVmed (PAVMZ)

PAVmed Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PAVMZ
DateTimeSourceHeadlineSymbolCompany
05/07/20248:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMZPAVmed Inc
01/17/20233:05PMBusiness WirePAVmed and Lucid Diagnostics Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
01/11/20237:00AMBusiness WirePAVmed and Lucid Diagnostics to Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
12/22/20227:25AMBusiness WirePAVmed Partners with Novosound on Ultrasound Imaging TechnologyNASDAQ:PAVMZPAVmed Inc
12/15/20227:25AMBusiness WirePAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care PlatformNASDAQ:PAVMZPAVmed Inc
12/08/20227:25AMBusiness WireLucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryNASDAQ:PAVMZPAVmed Inc
12/01/20227:25AMBusiness WireLucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchNASDAQ:PAVMZPAVmed Inc
11/14/20223:40PMBusiness WireLucid Diagnostics Provides Business Update and Third Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
11/11/20227:25AMBusiness WirePAVmed to Participate in BTIG Digital Health ForumNASDAQ:PAVMZPAVmed Inc
11/10/20227:25AMBusiness WireLucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:PAVMZPAVmed Inc
11/09/20227:25AMBusiness WireLucid Diagnostics Commences Production of EsoCheck Devices with High-Volume ManufacturerNASDAQ:PAVMZPAVmed Inc
11/03/20227:25AMBusiness WirePAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022NASDAQ:PAVMZPAVmed Inc
11/02/20227:25AMBusiness WireLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022NASDAQ:PAVMZPAVmed Inc
08/30/20227:25AMBusiness WirePAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech ConferenceNASDAQ:PAVMZPAVmed Inc
08/16/20223:40PMBusiness WirePAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
08/11/20227:25AMBusiness WireLucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and OhioNASDAQ:PAVMZPAVmed Inc
08/04/20227:25AMBusiness WireNewly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® TechnologiesNASDAQ:PAVMZPAVmed Inc
07/19/20227:25AMBusiness WirePAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate AmericaNASDAQ:PAVMZPAVmed Inc
07/18/20227:25AMBusiness WireLucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 ConferenceNASDAQ:PAVMZPAVmed Inc
05/13/20227:25AMBusiness WirePAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEONASDAQ:PAVMZPAVmed Inc
04/28/20223:05PMGlobeNewswire Inc.PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action LawsuitNASDAQ:PAVMZPAVmed Inc
04/26/20227:25AMBusiness WirePAVmed to Hold a Business Update Conference Call on May 12, 2022NASDAQ:PAVMZPAVmed Inc
03/29/20223:11PMBusiness WirePAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:PAVMZPAVmed Inc
03/23/20227:25AMBusiness WirePAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test CentersNASDAQ:PAVMZPAVmed Inc
03/17/20227:25AMBusiness WirePAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion SystemNASDAQ:PAVMZPAVmed Inc
03/10/20227:25AMBusiness WirePAVmed Subsidiary Veris Health Launches World-Class Technology Advisory BoardNASDAQ:PAVMZPAVmed Inc
03/08/20227:30AMBusiness WirePAVmed to Hold a Business Update Conference Call on March 29, 2022NASDAQ:PAVMZPAVmed Inc
03/07/20227:30AMBusiness WireLucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022NASDAQ:PAVMZPAVmed Inc
03/04/20227:25AMBusiness WireLucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech SummitNASDAQ:PAVMZPAVmed Inc
03/03/20227:25AMBusiness WirePAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing GrowthNASDAQ:PAVMZPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVMZ

Your Recent History

USOTC
SONG
Music Licensing (PK)
USOTC
EMGE
Emergent Health (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
CLNV
Clean Vision (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
NASDAQ
NVDA
NVIDIA
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved